×
切換帳號
臺大泌尿部/臺灣楓城泌尿學會
登入
繁體
简体
English
一般
中
大
索引
00:00
1.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:28
2.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:38
3.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:52
4.
Targeting prostate cancer cell with different mechanisms of action
02:16
5.
Targeting prostate cancer cell with different mechanisms of action
03:12
6.
[TITLE]
06:45
7.
Slide 4
07:55
8.
Slide 5
08:19
9.
Slide 6
08:59
10.
Slide 7
10:41
11.
Slide 8
11:36
12.
Why chemo-hormonal work better?
13:47
13.
Slide 10
15:30
14.
Slide 11
17:20
15.
Slide 10
17:23
16.
Slide 11
18:09
17.
Slide 12
20:56
18.
Slide 13
21:29
19.
Slide 14
22:56
20.
Slide 15
24:01
21.
Slide 16
25:00
22.
Prostate cancer is five different diseases, experts say
25:35
23.
Conclusion
26:07
24.
Slide 19
筆記
(0)
未登入或權限不足!
討論
影片問題
問卷
資訊卡
字幕
廣告
×
寫筆記
loading ...
00:00
1.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:28
2.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:38
3.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:52
4.
Targeting prostate cancer cell with different mechanisms of action
02:16
5.
Targeting prostate cancer cell with different mechanisms of action
03:12
6.
[TITLE]
06:45
7.
Slide 4
07:55
8.
Slide 5
08:19
9.
Slide 6
08:59
10.
Slide 7
10:41
11.
Slide 8
11:36
12.
Why chemo-hormonal work better?
13:47
13.
Slide 10
15:30
14.
Slide 11
17:20
15.
Slide 10
17:23
16.
Slide 11
18:09
17.
Slide 12
20:56
18.
Slide 13
21:29
19.
Slide 14
22:56
20.
Slide 15
24:01
21.
Slide 16
25:00
22.
Prostate cancer is five different diseases, experts say
25:35
23.
Conclusion
26:07
24.
Slide 19
×
嵌入網址
語法
複製語法
解析度
720x540
1024x768
自訂大小
原始碼嵌入
原始碼嵌入 (比例 4:3)
原始碼嵌入 (比例 16:9)
自訂大小
x
×
QR code
分享
Facebook
Twitter
LinkedIn
嵌入網址
QR code
索引
筆記
討論
全螢幕
列印日期 : 2025/04/06
臺大泌尿部/臺灣楓城泌尿學會
知識庫
...
2015臺大攝護祭-醫藥護人員場
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer—Why, When, and How?
長度: 29:53,
瀏覽: 722,
最近修訂: 2017-05-19
播放影片: http://urology.mc.ntu.edu.tw/media/188
×
×
複製檢核清單
loading ...
×
×
×
關閉
×
loading ...
下一篇
索引
討論
詳細
00:00
1.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:28
2.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:38
3.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer —Why, When, and How?
01:52
4.
Targeting prostate cancer cell with different mechanisms of action
02:16
5.
Targeting prostate cancer cell with different mechanisms of action
03:12
6.
[TITLE]
06:45
7.
Slide 4
07:55
8.
Slide 5
08:19
9.
Slide 6
08:59
10.
Slide 7
10:41
11.
Slide 8
11:36
12.
Why chemo-hormonal work better?
13:47
13.
Slide 10
15:30
14.
Slide 11
17:20
15.
Slide 10
17:23
16.
Slide 11
18:09
17.
Slide 12
20:56
18.
Slide 13
21:29
19.
Slide 14
22:56
20.
Slide 15
24:01
21.
Slide 16
25:00
22.
Prostate cancer is five different diseases, experts say
25:35
23.
Conclusion
26:07
24.
Slide 19
位置
知識庫
...
2015臺大攝護祭-醫藥護人員場
資料夾名稱
2015臺大攝護祭-醫藥護人員場
發表人
系統管理者
單位
泌尿部
建立
2017-05-19 16:54:24
最近修訂
2017-05-19 18:48:41
長度
29:53
知識庫
...
2015臺大攝護祭-醫藥護人員場
1.
Chemohormonal Therapy: New Paradigm in the Treatment of Metastatic Prostate Cancer—Why, When, and How?
2.
Bone‐Targeting Agents in Prostate Cancer Care– One Thing That is Underrated in Taiwan
3.
Sequential and Combination Therapy for mCRPC – What Do We Have and How Do We Apply?
4.
How Low Should Plasma Testosterone Level Be in the Treatment of Metastatic Prostate Cancer? ‐New Inspiration from Next Generation Hormonal Agents
5.
Active Surveillance or Watchful Waiting – How do They Apply to Your Patients?
6.
Radiotherapy from within The Bone For Patients with Metastatic Castration‐Resistant Prostate Cancer (mCRPC)
7.
Dissecting Lower Urinary Tract Symptoms–Pathophysiological and Pharmacological Perspectives
8.
Reappraisal of Published Randomized LUTS/BPH Clinical Trials–What Have We Learned and Where Do We Stand?
9.
Overactive Bladder and Urge Incontinence In Men: Current Oopinions, Medical and Surgical Management
10.
Nocturia and Nocturnal Enuresis
11.
Laser or Bipolar Enucleation of The Prostate